Can you recommend any clinical trials that might be candidates for me

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

I appreciate your question about clinical trials. However, I notice your message came through without the specific details about your cancer diagnosis and current status that would help me give you the most relevant guidance.

From your profile context, I can see you're a 10-year survivor with GG4 (which suggests Gleason Grade Group 4 prostate cancer), and you're now living in Israel. That's helpful context—but to recommend appropriate clinical trials, I'd need a bit more current information:

To help identify relevant trials, it would be useful to know:

  • What is your current PSA level and when was it last checked?
  • Have you had any recurrence or progression since your initial treatment?
  • What treatments have you already received (surgery, radiation, hormone therapy, chemotherapy)?
  • Are you currently on any active treatment or in surveillance?
  • Do you have any specific biomarkers tested (like BRCA mutations, mismatch repair status)?

How to find clinical trials tailored to YOUR situation:

The most reliable resources for finding trials matching your specific profile are:

  1. ClinicalTrials.gov (NIH) - You can search by cancer type, location (including Israel), and your specific criteria. This is the most comprehensive U.S. and international trial database.

  2. NCCN Guidelines for Prostate Cancer recommend discussing clinical trial eligibility with your oncologist, particularly for advanced or recurrent disease.

  3. American Cancer Society has a clinical trial matching service that can help identify appropriate studies.

  4. Your oncology team - This is crucial. Your doctor has access to trials through their institution and can identify which ones match YOUR specific pathology, biomarkers, and treatment history.

A key question to ask your healthcare team: "Based on my current PSA, Gleason score, and treatment history, what clinical trials am I eligible for, and which ones would you recommend discussing?"

Since you're in Israel, your oncologist may also have access to trials through Israeli cancer centers or European cooperative groups (ESMO guidelines reference international trial networks).

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2